Thank You!!

Two New Launch Announcements by Incyte

FDA Approves Label Expansion for ALUNBRIG(R) (brigatinib)

FDA Approved Darzalex Faspro

FDA Approved: Tabrecta (capmatinib) tablets

Spring Conference Exhibitors

Thank you to all of Sponsors for the Spring Conference

POHMS Annual Spring Conference And COVID-19

PADCEV FDA Approval Announcement

The FDA has approved PADCEV (enfortumab vedotin-ejfv) for the treatment of adult patients with locally advanced or metastatic urothelial cancer. Please see attached approval announcement for full details.